Destabilization of the dystrophin-glycoprotein complex without functional deficits in α-dystrobrevin null muscle

PLoS ONE

Volumn 3, Issue 7, 2008, Pages

  Bunnell, Tina M ^a   Jaeger, Michel A ^b   Fitzsimons, Daniel P ^b   Prins, Kurt W ^a   Ervasti, James M ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA DYSTROBREVIN; ALPHA DYSTROGLYCAN; DYSTROBREVIN; DYSTROPHIN; GLYCOPROTEIN; DYSTROPHIN ASSOCIATED PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; COMPLEX FORMATION; CONTROLLED STUDY; GASTROCNEMIUS MUSCLE; HISTOPATHOLOGY; MOUSE; MUSCLE ATROPHY; MUSCLE FUNCTION; MUSCLE NECROSIS; MUSCLE WEAKNESS; MUSCULAR DYSTROPHY; NONHUMAN; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN STABILITY; QUADRICEPS FEMORIS MUSCLE; TIBIALIS ANTERIOR MUSCLE; ANIMAL; CONFOCAL MICROSCOPY; GENETICS; METABOLISM; NEUROMUSCULAR SYNAPSE; SKELETAL MUSCLE; TRANSGENIC MOUSE;

MUS;

ANIMALS; DYSTROPHIN; DYSTROPHIN-ASSOCIATED PROTEINS; GLYCOPROTEINS; MICE; MICE, TRANSGENIC; MICROSCOPY, CONFOCAL; MUSCLE, SKELETAL; NEUROMUSCULAR JUNCTION;

EID: 49749093370     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0002604     Document Type: Article

References (44)

1. Ervasti JM (2007) Dystrophin, its interactions with other proteins, and implications for muscular dystrophy. Biochim Biophys Acta 1772: 108-117.
2. Petrof BJ, Shrager JB, Stedman HH, Kelly AM, Sweeney HL (1993) Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc Natl Acad Sci U S A 90: 3710-3714.
3. Blake DJ, Weir A, Newey SE, Davies KE (2002) Function and genetics of dystrophin and dystrophin-related proteins in muscle. Physiol Rev 82: 291-329.
4. Durbeej M, Campbell KP (2002) Muscular dystrophies involving the dystrophin-glycoprotein complex: an overview of current mouse models. Curr Opin Genet Dev 12: 349-361.
5. Hack AA, Groh ME, McNally EM (2000) Sarcoglycans in muscular dystrophy. Microsc Res Tech 48: 167-180.
6. Barresi R, Campbell KP (2006) Dystroglycan: from biosynthesis to pathogenesis of human disease. J Cell Sci 119: 199-207.
7. Dwyer TM, Frochner SC (1995) Direct binding of Torpedo syntrophin to dystrophin and the 87 kDa dystrophin homologue. FEBS Lett 375: 91-94.
8. Ahn XH, Freener CA, Gussoni E, Yoshida M, Ozawa E, et al. (1996) The three human syntrophin genes are expressed in diverse tissues, have distinct chromosomal locations, and each bind to dystrophin and its relatives. J Biol Chem 271: 2724-2730.
9. Sadoulet-Paccio HM, Rajala M, Kunkel LM, (1997) Dystrobrevin and dystrophin: an interaction through coiled-coil motifs. Proc Natl Acad Sci U S A 94:12413-12418.
10. Yoshida M, Hama H, Ishikawa-Sakurai M, Imamura M, Mizuno Y, et al. (2000) Biochemical evidence for association of dystrobrevin with the sarcoglycan-sarcospan complex as basis for understanding sarcoglycanopathy. Hum Mol Genet 9: 1033-1040.
11. Newey SE, Howman EV, Ponong CP, Benson MA, Nawrotzki R, et al. (2001) Syncoilin, a novel member of the intermediate filament superfamily that interacts with alpha-dystrobrevin in skeletal muscle. J Biol Chem 276: 6645-6655.
12. Mizuno Y, Thompson TG, Guyon JR, Lidov HG, Brosius M, et al. (2001) Desmuslin, an intermediate filament protein that interacts with alpha-dystrobrevin and desmin. Proc Natl Acad Sci U S A 98: 6156-6161.
13. Grady RM, Grange RW, Lau KS, Maimone MM, Nichol MC, et al. (1999) Role for alpha-dystrobrevin in the pathogenesis of dystrophin-dependent muscular dystrophies. Nat Cell Biol 1: 215-220.
14. Duclos F, Straub V, Moore SA, Venzke DP, Hrstka RF, et al. (1998) Progressive muscular dystrophy in alpha-sarcoglycan-deficient mice. J Cell Biol 142: 1461-1471.
15. Sasaoka T, Imamura M, Araishi K, Noguchi S, Mizuno Y, et al. (2003) Pathological analysis of muscle hypertrophy and degenration in muscular dystrophy in gamma-sarcoglycan-deficient mice. Neuromuscul Disord 13: 193-206.
16. Durbeej M, Cohn RD, Hrstka RF, Moore SA, Allamand V, et al. (2000) Disruption of the beta-sarcoglycan gene reveals pathogenetic complexity of limbgirdle muscular dystrophy type 2E. Mol Cell 5: 141-151.
17. Araishi K, Sasaoka T, Imamura M, Noguchi S, Hama H, et al. (1999) Loss of the sarcoglycan complex and sarcospan leads to muscular dystrophy in beta-sarcoglycan-deficient mice. Hum Mol Genet 8: 1589-1598.
18. Pastoret C, Sebille A (1995) mdx mice show progressive weakness and muscle deterioration with age. J Neurol Sci 129: 97-105.
19. Cote PD, Moukhles H, Lindenbaum M, Carbonetto S (1999) Chimaeric mice deficient in dystroglycans develop muscular dystrophy and have disrupted myoneural synapses. Nat Genet 23: 338-342.
20. Hack AA, Lam MY, Cordier L, Shoturma. DI, Ly CT, et al. (2000) Differential requirement for individual sarcoglycans and dystrophin in the assembly and function of the dystrophin-glycoprotein complex. J Cell Sci 113 (Pt 14): 2535-2544.
21. Grady RM, Zhou H, Cunningham JM, Henry MD, Campbell KP, et al. (2000) Maturation and maintenance of the neuromuscular synapse: genetic evidence for roles of the dystrophin-glycoprotein complex. Neuron 25: 279-293.
22. Ohlendieck K, Ervasti JM, Snook JB, Campbell KP (1991) Dystrophin-glycoprotein complex is highly enriched in isolated skeletal muscle sarcolemma. J Cell Biol 112: 135-148.
23. Williams MW, Bloch RJ (1999) Extensive but coordinated reorganization of the membrane skeleton in myofibers of dystrophic (mdx) mice. J Cell Biol 144: 1259-1270.
24. Reed P, Bloch RJ (2005) Postnatal changes in sarcolemmal organization in the mdx mouse. Neuromuscul Disord 15: 552-561.
25. Rybakova IN, Patel JR, Ervasti JM (2000) The dystrophin complex forms a mechanically strong link between the sarcolemma and costameric actin. J Cell Biol 150: 1209-1214.
26. Poon E, Howman EV, Newey SE, Davies KE (2002) Association of syncoilin and desmin: linking intermediate filament proteins to the dystrophin-associated. protein complex. J Biol Chem 277: 3433-3439.
27. O'Neill A, Williams MW, Resneck WG, Milner DJ, Capetanaki Y, et al. (2002) Sarcolemmal organization in skeletal muscle lacking desmin: evidence for cytokeratins associated with the membrane skeleton at costameres. Mol Biol Cell 13: 2347-2359.
28. Brooks SV, Zerba E, Faulkner JA (1995) Injury to muscle fibres after single stretches of passive and maximally stimulated muscles in mice. J Physiol 488 (Pt 2: 159-169.
29. Caulson CG, Makiejus RV (1990) A noninvasive procedure to detect muscle weakness in the mdx mouse. Muscle Nerve 13: 480-484.
30. Gordon T, Stein RB (1988) Comparison of force and stiffness in normal and dystrophic mouse muscles. Muscle Nerve 11: 819-827.
31. Balaban B, Matthews DJ, Clayton GH, Carry T (2005) Corticosteroid treatment and functional improvement in Duchenne muscular dystrophy: long-term effect. Am J Phy Med Rehabil 84: 843-850.
32. Keeling RM, Golumbek PT, Streif EM, Connolly AM (2007) Weekly oral prednisolone improves survival and strength in male mdx mice. Muscle Nerve 35: 43-48.
33. Deconinck N, Dan B (2007) Pathophysiology. of duchenne muscular dystrophy: current hypotheses. Pediatr Neurol 36: 1-7.
34. Warner LE, DelloRusso C, Crawford RW, Rybakova IN, Patel JR, et al. (2002) Expression of Dp260 in muscle tethers the actin cytoskeleton to the dystrophin-glycoprotein complex and partially prevents dystrophy. Hum Mol Genet 11: 1095-1105.
35. Thomas GD, Sander M, Lau KS, Huang PL, Stull JT, et al. (1998) Impaired metabolic modulation of alpha-adrenergic vasoconstriction in dystrophin-deficient skeletal muscle. Prioc Natl Acad Sci U S A 95: 15090-13095.
36. Coral-Vazquez R, Cohn RD, Moore SA, Hill JA, Weiss RM, et al. (1999) Disruption of the sarcoglycan-sarcospan complex in vascular smooth muscle: a novel mechanism for cardiomyopathy and muscular dystrophy. Cell 98: 465-474.
37. Chao DS, Silvagno F, Bredt DS (1998) Muscular dystrophy in mdx mice despite lack of neuronal nitric oxide synthase. J Neurochem 71: 784-789.
38. McCullagh KJ, Edwards B, Poon E, Lovering RM, Paulin D, et al. (2007) Intermediate filament-like protein syncoilin in normal and myopathic striated muscle. Neuromuscul Disord.
39. Akaaboune M, Grady RM, Turney S, Sanes JR, Lichtman JW (2002) Neurotransmitter receptor dynamics studied in vivo by reversible photo-unbinding of fluorescent ligands. Neuron 34: 865-876.
40. Jacobson C, Cote PD, Rossi SG, Rotundo RL, Carbonetto S (2001) The dystroglycan complex is necessary for stabilization of acetylcholine receptor clusters at neuromuscular junctions and formation of the synaptic basement membrane. J Cell Biol 152: 435-450.
41. Martinez P, Akaaboune M (2007) Acetylcholinesterase mobility and stability at the neuromuscular junction of living mice. Mol Biol Cell 18: 2904-2911.
42. Gieseler K, Mariol MC, Bessou C, Migaud M, Franks CJ, et al. (2001) Molecular, genetic and physiological characterisation of dystrobrevin-like (dyb-1) mutants of Caenorhabditis elegans. J Mol Biel 307: 107-117.
43. Sonnemann KJ, Fitzsimous DP, Patel JR, Liu Y, Schneider MF, et al. (2006) Cytoplasmic gamma-actin is not required for skeletal muscle development but its absence leads to a progressive myopathy. Dev Cell 11: 387-397.
44. Brooks SV, Faulkner JA (1988) Contractile properties of skeletal muscles from young, adult and aged mice. J Physiol 404: 71-82.